De Scheerder I - Search Results

1

L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism.

Vermeersch P, Nong Z, Stabile E, Varenne O, Gillijns H, Pellens M, Van Pelt N, Hoylaerts M, De Scheerder I, Collen D, Janssens S. Vermeersch P, et al. Among authors: de scheerder i. Arterioscler Thromb Vasc Biol. 2001 Oct;21(10):1604-9. doi: 10.1161/hq1001.096645. Arterioscler Thromb Vasc Biol. 2001. PMID: 11597933

2

Clinical and Angiographic Experience with Coronary Stenting Using Freedomª Stent.

DeScheerder IK, Wang K, Kerdsinchai P, Supanantaroek C, Piessens JH. DeScheerder IK, et al. J Invasive Cardiol. 1996 Nov;8(9):418-427. J Invasive Cardiol. 1996. PMID: 10785743

3

Pharmaceutical aspects of drug eluting stents.

Deconinck E, Sohier J, De Scheerder I, Van den Mooter G. Deconinck E, et al. Among authors: de scheerder i. J Pharm Sci. 2008 Dec;97(12):5047-60. doi: 10.1002/jps.21356. J Pharm Sci. 2008. PMID: 18384155 Review.

4

Two-year clinical results of a polymer-free, paclitaxel-eluting stent: the ELUTES trial.

Swanson N, De Scheerder I, Chevalier B, Camenzind E, Carver A, Gershlick A. Swanson N, et al. Among authors: de scheerder i. EuroIntervention. 2007 May;3(1):109-12. EuroIntervention. 2007. PMID: 19737693

5

Stent-based tempamine delivery on neointimal formation in a porcine coronary model.

Huang Y, Wang L, Li S, Liu X, Lee K, Verbeken E, van de Werf F, de Scheerder I. Huang Y, et al. Among authors: de scheerder i. Acute Card Care. 2006;8(4):210-6. doi: 10.1080/17482940600949661. Acute Card Care. 2006. PMID: 17162547

6

Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.

Salu KJ, Bosmans JM, Huang Y, Hendriks M, Verhoeven M, Levels A, Cooper S, De Scheerder IK, Vrints CJ, Bult H. Salu KJ, et al. Among authors: de scheerder ik. Cardiovasc Res. 2006 Feb 1;69(2):536-44. doi: 10.1016/j.cardiores.2005.11.012. Epub 2005 Dec 28. Cardiovasc Res. 2006. PMID: 16386237

7

Stent-mediated methylprednisolone delivery reduces macrophage contents and in-stent neointimal formation.

Wang L, Salu K, Verbeken E, Bosmans J, Van de Werf F, De Scheerder I, Huang Y. Wang L, et al. Among authors: de scheerder i. Coron Artery Dis. 2005 Jun;16(4):237-43. doi: 10.1097/00019501-200506000-00005. Coron Artery Dis. 2005. PMID: 15915076

8

Use of a tacrolimus-eluting stent to inhibit neointimal hyperplasia in a porcine coronary model.

Huang Y, Salu K, Wang L, Liu X, Li S, Lorenz G, Wnendt S, Verbeken E, Bosmans J, Van de Werf F, De Scheerder I. Huang Y, et al. Among authors: de scheerder i. J Invasive Cardiol. 2005 Mar;17(3):142-8. J Invasive Cardiol. 2005. PMID: 15867441

9

Direct stenting versus direct stenting followed by centered beta-radiation with intravascular ultrasound-guided dosimetry and long-term anti-platelet treatment: results of a randomized trial: Beta-Radiation Investigation with Direct Stenting and Galileo in Europe (BRIDGE).

Serruys PW, Wijns W, Sianos G, de Scheerder I, van den Heuvel PA, Rutsch W, Glogar HD, Macaya C, Materne PH, Veldhof S, Vonhausen H, Otto-Terlouw PC, van der Giessen WJ. Serruys PW, et al. Among authors: de scheerder i. J Am Coll Cardiol. 2004 Aug 4;44(3):528-37. doi: 10.1016/j.jacc.2004.03.077. J Am Coll Cardiol. 2004. PMID: 15358015 Free article. Clinical Trial.

10

Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis.

Liu X, De Scheerder I, Desmet W. Liu X, et al. Among authors: de scheerder i. Expert Rev Cardiovasc Ther. 2004 Sep;2(5):653-60. doi: 10.1586/14779072.2.5.653. Expert Rev Cardiovasc Ther. 2004. PMID: 15350167 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters